Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common di…
$2.80+19.15%
报价 2026-11-16
市值
$34.6M
EV
$23M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -55.4%
$2.35$6.28
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NMADNOMAD Power Solutions, Inc. | $34.6M | +19.1% | – | – | – | – | – | |
| ALPSAlps Group Inc | $36.4M | -2.5% | – | 38.6% | – | – | – | |
| IMAImageneBio Inc | $36.3M | -7.8% | 0.0% | 0% | – | – | – | |
| VERUVeru Inc. | $35.5M | -0.5% | +48.1% | 0% | – | – | – | |
| TELOTelomir Pharmaceuticals, Inc. Common Stock | $35.4M | -2.0% | -99.9% | 0% | – | – | – | |
| RANIRani Therapeutics Holdings, Inc. | $35.3M | +2.7% | -13.5% | 96.7% | – | – | – | |
| KLRSKalaris Therapeutics Inc | $34.8M | -7.3% | -100.0% | 0% | – | – | – | |
| ONCYOncolytics Biotech Inc. | $34.1M | -8.1% | – | 0% | – | – | – | |
| ATHEAlterity Therapeutics Limited | $33.2M | -6.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | -13.5% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。